Anti Viral News -

Favipiravir

https://en.wikipedia.org/wiki/Favipiravir

Favipiravir, also known as T-705, Avigan, or favilavir is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses. In February 2020 Favipiravir was being studied in China for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.[1][2] On March 17 it was found to be effective in treating the infection in two trials in Wuhan and Shenzhen.

https://www.nationthailand.com/news/30384348

Antiviral drug on the way from China

National

Mar 18. 2020

Some 120,000 tablets of Favipiravir, an antiviral drug, will be imported for the battle against Covid-19, Public Health Minister Anutin Charnvirakul said on Wednesday (March 18).

>>8462213

https://www.theguardian.com/world/2020/mar/18/japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china

Japanese flu drug 'clearly effective' in treating coronavirus, says China

Shares in Fujifilm Toyama Chemical, which developed favipiravir, surged after praise by Chinese official following clinical trials

"Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.

In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug."